Sigma-Aldrich Fine Chemicals Introduces Surplus Inventory Online
Buyers Can Name Their Own Price On Hundreds of Surplus Items Available Online
"Market changes have caused the creation of a surplus chemical inventory of hundreds of Sigma-Aldrich products. Out of this excess inventory was borne Sigma-Aldrich Surplus Solutions. The products offered are the same high-quality, name brand products that the chemical industry has come to expect from Sigma-Aldrich. By offering buyers the opportunity to name their own price, we believe that we have found a solution for customers who hope to buy quality products at tremendous savings, as well as a solution to our surplus stock" said Tom Berger, internet marketing manager for Sigma-Aldrich Fine Chemicals. "The site is exceptionally easy to use. Visitors can browse inventory alphabetically, name the price they feel is fair, and we'll contact them within 24 hours to advise whether their bid is acceptable," said Berger.
Sigma-Aldrich Surplus Solutions launched in November 2000. The company will maintain a rolling inventory on the site by adding all new surplus inventory as it becomes available.
The Sigma-Aldrich family of companies develops, manufactures and distributes one of the broadest ranges of high-quality biochemicals and organic chemicals in the world. Through Sigma-Aldrich Fine Chemicals, these products are available in large scale at competitive prices for the development and manufacture of pharmaceutical, biopharmaceutical, and high-technology chemical products.
This release contains forward-looking statements relating to future performance, goals, actions and initiatives and similar intentions and beliefs which involve assumptions regarding Company operations, investments and conditions in the markets the Company serves. Although the Company believes its expectations are based on reasonable assumptions, such statements are subject to risk and uncertainty, including, among others, certain economic, political and technological factors. Actual results could differ materially from those stated or implied in this news release, due to, but not limited to, such factors as changes in the business environment in which the Company operates, changes in research funding, uncertainties surrounding government healthcare reform and government regulations applicable to the business. The Company does not undertake any obligation to update these forward-looking statements.